TY - JOUR
T1 - All thresholds of maternal hyperglycaemia from the WHO 2013 criteria for gestational diabetes identify women with a higher genetic risk for type 2 diabetes [version 2; peer review
T2 - 3 approved with reservations]
AU - Hughes, Alice E.
AU - Hayes, M. Geoffrey
AU - Egan, Aoife M.
AU - Patel, Kashyap A.
AU - Scholtens, Denise M.
AU - Lowe, Lynn P.
AU - Lowe, William L.
AU - Dunne, Fidelma P.
AU - Hattersley, Andrew T.
AU - Freathy, Rachel M.
N1 - Funding Information:
Grant information: This work was supported by Wellcome [GW4 Clinical Academic Training PhD Fellowship to AEH; 110082, Postdoctoral Training Fellowship to KAP; 104150, a Wellcome and Royal Society Sir Henry Dale Fellowship to RMF; 088541, a Sir Henry Wellcome Postdoctoral Fellowship to RMF was used to fund genotyping of the SNPs in HAPO and DIP]. AEH was also funded by the National Institute of Health Research (NIHR). ATH is a Wellcome Trust Senior Investigator (098395) and NIHR senior investigator. HAPO was supported by grants from Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-34242 and HD-32423), National Human Genome Research Institute (HG-004415), the National Institute of Diabetes and Digestive and Kidney Diseases (DK-DK097534) and the American Diabetes Association. DIP was supported by grants from the Ireland Health Research Board.
Publisher Copyright:
© 2020. Hughes AE et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
PY - 2020
Y1 - 2020
N2 - Background: Using genetic scores for fasting plasma glucose (FPG GS) and type 2 diabetes (T2D GS), we investigated whether the fasting, 1-hour and 2-hour glucose thresholds from the WHO 2013 criteria for gestational diabetes (GDM) have different implications for genetic susceptibility to raised fasting glucose and type 2 diabetes in women from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) and Atlantic Diabetes in Pregnancy (DIP) studies. Methods: Cases were divided into three subgroups: (i) FPG ≥5.1 mmol/L only, n=222; (ii) 1-hour glucose post 75 g oral glucose load ≥10 mmol/L only, n=154 (iii) 2-hour glucose ≥8.5 mmol/L only, n=73; and (iv) both FPG ≥5.1 mmol/L and either of a 1-hour glucose ≥10 mmol/L glucose ≥8.5 mmol/L, n=172. We compared the FPG and T2D GS of these groups with controls (n=3,091) in HAPO and DIP separately. Results: In HAPO and DIP, the mean FPG GS in women with a FPG ≥5.1 mmol/L, either on its own or with 1-hour glucose ≥10 mmol/L or 2-hour glucose ≥8.5 mmol/L, was higher than controls (all P <0.01). Mean T2D GS in women with a raised FPG alone or with either a raised 1-hour or 2-hour glucose was higher than controls (all P <0.05). GDM defined by 1-hour or 2-hour hyperglycaemia only was also associated with a higher T2D GS than controls (all P <0.05). Conclusions: The different diagnostic categories that are part of the predisposition to type 2 diabetes as well as a risk for adverse pregnancy outcomes.
AB - Background: Using genetic scores for fasting plasma glucose (FPG GS) and type 2 diabetes (T2D GS), we investigated whether the fasting, 1-hour and 2-hour glucose thresholds from the WHO 2013 criteria for gestational diabetes (GDM) have different implications for genetic susceptibility to raised fasting glucose and type 2 diabetes in women from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) and Atlantic Diabetes in Pregnancy (DIP) studies. Methods: Cases were divided into three subgroups: (i) FPG ≥5.1 mmol/L only, n=222; (ii) 1-hour glucose post 75 g oral glucose load ≥10 mmol/L only, n=154 (iii) 2-hour glucose ≥8.5 mmol/L only, n=73; and (iv) both FPG ≥5.1 mmol/L and either of a 1-hour glucose ≥10 mmol/L glucose ≥8.5 mmol/L, n=172. We compared the FPG and T2D GS of these groups with controls (n=3,091) in HAPO and DIP separately. Results: In HAPO and DIP, the mean FPG GS in women with a FPG ≥5.1 mmol/L, either on its own or with 1-hour glucose ≥10 mmol/L or 2-hour glucose ≥8.5 mmol/L, was higher than controls (all P <0.01). Mean T2D GS in women with a raised FPG alone or with either a raised 1-hour or 2-hour glucose was higher than controls (all P <0.05). GDM defined by 1-hour or 2-hour hyperglycaemia only was also associated with a higher T2D GS than controls (all P <0.05). Conclusions: The different diagnostic categories that are part of the predisposition to type 2 diabetes as well as a risk for adverse pregnancy outcomes.
KW - Gestational diabetes
KW - fasting plasma glucose
KW - genetic scores
KW - type 2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85117944922&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117944922&partnerID=8YFLogxK
U2 - 10.12688/WELLCOMEOPENRES.16097.2
DO - 10.12688/WELLCOMEOPENRES.16097.2
M3 - Article
AN - SCOPUS:85117944922
SN - 2398-502X
VL - 5
SP - 1
EP - 28
JO - Wellcome Open Research
JF - Wellcome Open Research
ER -